AI Tools for Hematology

Blood disorders, anticoagulation, hematologic malignancies.

34 companies also serving Hematology →

43 results

Tools for Hematology, by category

Lab & Diagnostics (22) Pathology AI (18) Oncology AI (15) Drug Discovery & Research (12) Clinical Decision Support & Reference (7) Pharmacology & Dosing AI (2) Radiology & Imaging AI (2) Developer Tools & APIs (1) EMR / EHR Systems (1) Gastroenterology AI (1) Medical Education & Training (1) Patient Engagement & Education (1) Practice Analytics & BI (1)
23andMe Personal Genome Service (PGS) Genetic Health Risk Test for Hereditary Thrombophilia
23andMe
Clinical Decision Support & Reference
The 23andMe Personal Genome Service (PGS) Genetic Health Risk Test for Hereditary Thrombophilia is an FDA-cleared direct-to-consumer genetic test that identifies specific genetic variants (Factor V Leiden and Prothrombin G20210A) associated with an increased risk of developing harmful blood clots. It provides personal genetic insights for proactive health discussions with healthcare professionals.
$199
Advanced RBC Application
CellaVision AB
Lab & Diagnostics
CellaVision Advanced RBC Application is an AI-powered software module that automates and standardizes the morphological examination of red blood cells, complementing peripheral blood smears for enhanced diagnostic efficiency in hematology labs.
Contact for pricing
AI100
SigTuple Technologies Pvt.
Lab & Diagnostics
SigTuple AI100 is an AI-powered in-vitro diagnostic device that automates the microscopic analysis of blood and urine samples, enhancing diagnostic accuracy and efficiency for pathology labs and hospitals.
Contact vendor for pricing details.
AnovaOS
Anova Enterprises
Drug Discovery & Research
AnovaOS is an AI-based patient matching solution for clinical trials that leverages AI to match molecular, demographic, and clinical history data against eligibility criteria from active trials. It connects patients to over 200,000 open clinical trials with high-confidence eligibility matching.
Free for participating research sites.
ASCO Guidelines Assistant
American Society of Clinical Oncology (ASCO) / Google Cloud
Clinical Decision Support & Reference
The ASCO Guidelines Assistant is an AI tool, developed by ASCO and Google Cloud, that helps oncologists quickly access evidence-based clinical guidelines, providing timely and trustworthy information to support patient care decisions.
Paid membership
Athelas Home
Athelas
Lab & Diagnostics
Athelas Home is an FDA-cleared, AI-powered hematology analyzer that provides rapid white blood cell and neutrophil percentage results from a fingerstick for point-of-care and home use, streamlining patient monitoring and clinical decision-making.
Variable
Athelas One
Athelas
Lab & Diagnostics
Athelas One is an FDA-cleared, AI-powered portable blood diagnostic device that provides rapid white blood cell and neutrophil percentage counts from a fingerstick or venous blood sample for point-of-care and clinical laboratory use. It is not a physician directory tool.
Contact vendor for pricing
AtomNet
Atomwise
Drug Discovery & Research
Atomwise's AtomNet platform uses structure-based AI modeling and deep learning to predict how small molecules will bind to specific proteins, screening billions of compounds against disease targets to accelerate drug discovery.
Partnership agreements with pharma companies, biotech firms, and academic institutions.
Cancer Copilot
Color Health
Oncology AI
Color Health's Cancer Copilot, built with OpenAI, helps oncologists and clinicians identify and order workup needs for recently diagnosed patients, aiming to speed up time to cancer treatment. This AI tool is designed to expand cancer expertise, speed decisions, and improve care, reducing a two-hour clinical task to 10 minutes with over 95% validated accuracy.
CancerLinQ SmartLinQ (RxLinQ & TriaLinQ)
ConcertAI (an ASCO initiative)
Clinical Decision Support & Reference
CancerLinQ SmartLinQ (RxLinQ & TriaLinQ) is a precision oncology platform by ConcertAI that uses AI and real-world data to identify patients for new therapies and clinical trials, streamlining oncology workflows.
Contact for pricing
CellaVision DC-1
CellaVision AB
Lab & Diagnostics
CellaVision DC-1 is an AI-powered digital cell morphology analyzer that automates and standardizes blood cell differentials in low-volume hematology laboratories, enhancing efficiency and diagnostic accuracy through digital imaging and pre-classification.
Not available publicly
CellaVision DM Series
CellaVision (part of Sysmex)
Lab & Diagnostics
CellaVision DM Series are AI-powered digital morphology systems that automate and standardize the review of blood and body fluid smears, assisting in the classification of cells for hematology diagnostics. They leverage artificial intelligence, deep learning, and digital imaging to standardize and simplify manual cell morphology analysis.
Contact vendor for pricing
CELLAVISION DM1200 WITH THE BODY FLUID APPLICTION
CELLAVISION AB
Lab & Diagnostics
The CellaVision DM1200 with the Body Fluid Application is an FDA-cleared automated digital cell morphology system that uses AI and robotics to simplify and standardize blood and body fluid differentials in hematology labs.
Contact for pricing
CELLAVISION DM96 AUTOMATIC HEMATOLOGY ANALYZER
CELLAVISION AB
Lab & Diagnostics
The CellaVision DM96 Automatic Hematology Analyzer was an automated image analysis system that revolutionized hematology laboratories by providing digital solutions for differential counting of white blood cells and characterization of red blood cells, leveraging AI for pre-classification and enhancing workflow efficiency.
Contact vendor for pricing
CELLAVISION DM96 WITH THE BODY FLUID APPLICATION
CELLAVISION AB
Lab & Diagnostics
The CellaVision DM96 with the Body Fluid Application is an FDA-cleared automated digital morphology system that uses AI to analyze and pre-classify cells in blood and various body fluid samples, enhancing diagnostic efficiency and standardization in hematology laboratories.
Contact vendor for pricing
AI Tool Finder
AI-powered search. Results may not be comprehensive.